Reprocell develops stem cell technologies. Read more

110 Followers on Owler
110 Followers on Owler
110 Followers on Owler
110 Followers on Owler

Reprocell develops stem cell technologies. Read more

Chikafumi Yokoyama's photo - CEO of REPROCELL

CEO

Chikafumi Yokoyama

CEO Approval Rating

89/100

Founded:

2003

Status:

PrivateIndependent Company

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

DefiniGEN is REPROCELL's top competitor. DefiniGEN is a Private company that was founded in Cambridge, England in 2013. DefiniGEN operates in the Biotechnology industry. DefiniGEN has 40 fewer employees vs. REPROCELL.

Axol has been one of REPROCELL's top competitors. Axol is headquartered in Cambridgeshire, England, and was founded in 2012. Axol is in the Biotechnology field. Axol generates 30% the revenue of REPROCELL.

Cell Applications is perceived as one of REPROCELL's biggest rivals. Cell Applications was founded in 1994 in San Diego, California. Cell Applications competes in the Biotechnology field. Cell Applications generates $4.9M less revenue than REPROCELL.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 60 a good estimate for REPROCELL's Employee count?

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Apr 2018

Source »
$1.9M
-
Biopta Ltd.

Nov 2015

Source »
$8.3M
Biopta is a contract research organization that provides non-clinical drug development services to pharmaceutical companies.

These are all the companies that REPROCELL has acquired. REPROCELL has acquired 2 companies and its latest acquisition was in Apr 2018.

REPROCELL Funding History

$350K

Since REPROCELL was founded in 2003, it has participated in 1 round of funding. In total REPROCELL has raised $350.0K. REPROCELL's funding round was on May 2020 for a total of $350.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
May 2020
$350K - $1M

U.S. Small Business Administration.

Since REPROCELL was founded in 2003, it has participated in 1 round of funding. In total REPROCELL has raised $350.0K. REPROCELL's funding round was on May 2020 for a total of $350.0K

Investments

No recent investments found related to REPROCELL

These are all the companies that REPROCELL has invested in. REPROCELL has invested 2 companies and its latest investment was in Apr 2018.

REPROCELL News

March 14, 2019Manufacturing Chemist

REPROCELL joins Medicines Discovery Catapult†s Virtual R and D network

REPROCELL will provide custom drug discovery assays using live human tissues to improve the predictio... See more »
November 17, 2018BioPortfolio

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23102018 Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell ... See more »
October 19, 20184-traders

The importance of internships for life science students

(marketscreener.com) If you are a science student nearing the end of your university program, develop... See more »
July 28, 2018BioPortfolio

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell ... See more »
May 25, 20184-traders

Do animal experiments translate to humans? A report by Elsevier and Bayer uses big data to shed new light on a hotly debated topic

(4-traders.com) The use of animals to predict the risk of adverse effects in humans is a long-standin... See more »
May 9, 2018BioPortfolio

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell ... See more »
April 27, 2018PharmiWeb

Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated

Cancer Genetics Announces Sale of India Operations to REPROCELL IncorporatedExecution of 2018 Transfo... See more »

REPROCELL Blogs

September 15, 2020Reprocell Blog

StemFit®: How to create a renal vascular system in vitro [INTERVIEW]

The kidney is a vital organ that continuously filters blood and maintains fluid homeostas... See more »
September 11, 2020Reprocell Blog

What is translational research?

In recent years, there has been an increased focus on the benefits of translational resea... See more »
September 4, 2020Reprocell Blog

StemFit: iPSCs for corneal epithelial stem cell deficiency [INTERVIEW]

In August 2019, Osaka University reported the world’s first transplantation of a corneal ... See more »
September 1, 2020Reprocell Blog

This light-activated treatment could help patients with peripheral artery disease (PAD)

More than 200 million people are affected by peripheral artery diseases (PAD) worldwide [... See more »
August 3, 2020Reprocell Blog

4 Examples of human models of respiratory diseases

Respiratory diseases are a global health burden [1], with 65 million people worldwid... See more »
July 14, 2020Reprocell Blog

Using 3D culture to improve Caco-2 permeability assays

Drug discovery, development and validation for use in the clinic is a long and expensive ... See more »
July 13, 2020Reprocell Blog

Why this intranasal vaccine may offer a long-term solution to COVID

REPROCELL has recently joined an international consortium, led by Belgium company etheRNA... See more »

REPROCELL Press Releases

January 11, 2018Business Wire

Global Industry Analysis, Trends, Market Size and Forecasts 2016-2023 - Research and Markets

DUBLIN--(BUSINESS WIRE)--The "Tissue Engineering Market: Global Industry Analysis, Trends, Market Siz... See more »
December 13, 2017GlobeNewswire

Q Therapeutics Announces Research Collaboration With REPROCELL

Partnership Explores New Cell Therapies for Central Nervous System Diseases Using IPSC-Derived Produc... See more »
November 26, 2015Business Wire

Regarding the Synergistic Effects of Our Complete Subsidiary Acquisition of Biopta Limited

YOKOHAMA, Japan--(BUSINESS WIRE)--ReproCELL, Inc. (JASDAQ: 4978) announces that at a director meeting... See more »
November 25, 2015B3C Group

ReproCELL Acquires Biopta To Expand Its Drug Discovery Services

Glasgow, UK, November 25, 2015 / B3C newswire / -- The Japanese regenerative medicine company ReproCE... See more »
September 24, 2015PR-INSIDE.COM

ReproCELL Inc. (4978) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) ReproCELL Inc. (ReproCELL) is a biotechnology company. The company develops and comme... See more »
August 26, 2015BUSINESS WIRE

New High-performance Cryopreservation Solution for Human ES/iPS Cells Used in Regenerative Medicine Notice of the Commencement of Sales of "ReproCryo DMSO free"

YOKOHAMA, Japan--(BUSINESS WIRE)--We hereby wish to inform you that, on August 20th 2015, in conjunct... See more »
July 22, 2015BUSINESS WIRE

Sales Commencement of "ReproNeuro MQ Medium", a Cell Culture Kit Which Enables the Creation of High-Functioning Nerve Cells Derived from Human iPS Cells

YOKOHAMA, Japan--(BUSINESS WIRE)--Announcing the sales commencement of "ReproNeuro MQ Medium", a cell... See more »

REPROCELL Videos

Social Media

Headquarters

9000 Virginia Manor Road Suite 207

Beltsville, Maryland20705

1-301-470-3362

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Reprocell develops stem cell technologies. REPROCELL was founded in 2003. REPROCELL's headquarters is located in Beltsville, Maryland, USA 20705. It has raised 350.0K in 1 round. The latest round was in May 2020. REPROCELL's primary investor is U.S. S...

CEO

REPROCELL's CEO, Chikafumi Yokoyama, currently has an approval rating of 89%. REPROCELL's primary competitors are DefiniGEN, Axol & Cell Applications.

Website

reprocell.com

Frequently Asked Questions about REPROCELL

  1. When was REPROCELL founded?

    REPROCELL was founded in 2003
  2. Who is REPROCELL's CEO?

    REPROCELL's CEO is Chikafumi Yokoyama
  3. How much revenue does REPROCELL generate?

    REPROCELL generates $9.8M in revenue
  4. How much funding does REPROCELL have?

    REPROCELL has historically raised $350K in funding
  1. Where is REPROCELL's headquarters?

    REPROCELL's headquarters is in Beltsville Maryland, USA
  2. How many employees does REPROCELL have?

    REPROCELL has 60 employees
  3. What sector does REPROCELL operate in?

    REPROCELL is in Biotechnology
  4. Who are REPROCELL's competitors?

    REPROCELL's top competitors are DefiniGEN, Axol, Cell Applications